CN102367263A - 一种分离纯化积雪草三萜酸单葡萄糖苷的方法 - Google Patents
一种分离纯化积雪草三萜酸单葡萄糖苷的方法 Download PDFInfo
- Publication number
- CN102367263A CN102367263A CN2011103584218A CN201110358421A CN102367263A CN 102367263 A CN102367263 A CN 102367263A CN 2011103584218 A CN2011103584218 A CN 2011103584218A CN 201110358421 A CN201110358421 A CN 201110358421A CN 102367263 A CN102367263 A CN 102367263A
- Authority
- CN
- China
- Prior art keywords
- glucoside
- glycosides
- list glucoside
- nsc
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002253 acid Substances 0.000 title claims abstract description 44
- 238000000034 method Methods 0.000 title claims abstract description 16
- 244000146462 Centella asiatica Species 0.000 title abstract description 11
- 235000004032 Centella asiatica Nutrition 0.000 title abstract description 11
- 150000003648 triterpenes Chemical class 0.000 title abstract 6
- PRAUVHZJPXOEIF-AOLYGAPISA-N madecassic acid Chemical compound C1[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]2[C@H](O)C[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C PRAUVHZJPXOEIF-AOLYGAPISA-N 0.000 claims abstract description 74
- 229940011656 madecassic acid Drugs 0.000 claims abstract description 73
- BUWCHLVSSFQLPN-UHFFFAOYSA-N madecassic acid Natural products CC1CCC2(CCC3(C)C(=CCC4C5(C)CC(O)C(O)C(C)(C5CCC34C)C(=O)O)C2C1C)C(=O)OC6OC(COC7OC(CO)C(OC8OC(C)C(O)C(O)C8O)C(O)C7O)C(O)C(O)C6O BUWCHLVSSFQLPN-UHFFFAOYSA-N 0.000 claims abstract description 73
- JXSVIVRDWWRQRT-UYDOISQJSA-N asiatic acid Chemical compound C1[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C JXSVIVRDWWRQRT-UYDOISQJSA-N 0.000 claims abstract description 64
- 229920000858 Cyclodextrin Polymers 0.000 claims abstract description 20
- 239000001116 FEMA 4028 Substances 0.000 claims abstract description 20
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims abstract description 20
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims abstract description 20
- 229960004853 betadex Drugs 0.000 claims abstract description 20
- 238000001035 drying Methods 0.000 claims abstract description 14
- 238000004440 column chromatography Methods 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 207
- 229930182478 glucoside Natural products 0.000 claims description 164
- 150000008131 glucosides Chemical class 0.000 claims description 164
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 82
- 229930182470 glycoside Natural products 0.000 claims description 71
- 150000002338 glycosides Chemical class 0.000 claims description 71
- 239000004744 fabric Substances 0.000 claims description 39
- 239000000203 mixture Substances 0.000 claims description 35
- 241000167550 Centella Species 0.000 claims description 27
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 claims description 26
- 239000002904 solvent Substances 0.000 claims description 24
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 20
- 239000000741 silica gel Substances 0.000 claims description 19
- 229910002027 silica gel Inorganic materials 0.000 claims description 19
- 229960001866 silicon dioxide Drugs 0.000 claims description 19
- 238000004587 chromatography analysis Methods 0.000 claims description 18
- 230000001476 alcoholic effect Effects 0.000 claims description 14
- 238000001953 recrystallisation Methods 0.000 claims description 14
- 238000003756 stirring Methods 0.000 claims description 14
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 12
- 238000002425 crystallisation Methods 0.000 claims description 11
- 238000005520 cutting process Methods 0.000 claims description 11
- 239000003960 organic solvent Substances 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 9
- 238000000746 purification Methods 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 8
- 238000004262 preparative liquid chromatography Methods 0.000 claims description 8
- 238000000926 separation method Methods 0.000 claims description 8
- 239000012043 crude product Substances 0.000 claims description 4
- 238000010898 silica gel chromatography Methods 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 2
- 230000008025 crystallization Effects 0.000 claims description 2
- 239000010419 fine particle Substances 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 claims description 2
- 239000003791 organic solvent mixture Substances 0.000 claims description 2
- DZVIFFMYEULLBY-UHFFFAOYSA-N Chebuloside II Natural products C1CC(C2(CC(O)C3C(C)(CO)C(O)C(O)CC3(C)C2CC=2)C)(C)C=2C2CC(C)(C)CCC21C(=O)OC1OC(CO)C(O)C(O)C1O DZVIFFMYEULLBY-UHFFFAOYSA-N 0.000 abstract description 2
- DZVIFFMYEULLBY-ZBNHRINCSA-N [(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (4as,6ar,6as,6br,8r,8ar,9r,10r,11r,12ar,14bs)-8,10,11-trihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate Chemical compound O=C([C@]12CCC(C[C@H]1C=1[C@@]([C@@]3(C[C@@H](O)[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)(C)C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DZVIFFMYEULLBY-ZBNHRINCSA-N 0.000 abstract description 2
- 229940011658 asiatic acid Drugs 0.000 abstract description 2
- LBGFKBYMNRAMFC-PYSQTNCISA-N asiatic acid Natural products C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@@]34C)[C@]2(C)[C@H]1C)C(=O)O LBGFKBYMNRAMFC-PYSQTNCISA-N 0.000 abstract description 2
- CLXOLTFMHAXJST-UHFFFAOYSA-N esculentic acid Natural products C12CC=C3C4CC(C)(C(O)=O)CCC4(C(O)=O)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(CO)C CLXOLTFMHAXJST-UHFFFAOYSA-N 0.000 abstract description 2
- 238000011031 large-scale manufacturing process Methods 0.000 abstract description 2
- 239000007864 aqueous solution Substances 0.000 description 13
- 239000000243 solution Substances 0.000 description 11
- 238000004128 high performance liquid chromatography Methods 0.000 description 10
- 238000001816 cooling Methods 0.000 description 9
- 238000010438 heat treatment Methods 0.000 description 9
- 239000012047 saturated solution Substances 0.000 description 9
- DORPKYRPJIIARM-UHFFFAOYSA-N Decaffeoylacteoside Natural products OC1C(O)C(O)C(C)OC1OC1C(O)C(OCCC=2C=C(O)C(O)=CC=2)OC(CO)C1O DORPKYRPJIIARM-UHFFFAOYSA-N 0.000 description 5
- DORPKYRPJIIARM-GYAWPQPFSA-N Verbasoside Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O)[C@H](OCCC=2C=C(O)C(O)=CC=2)O[C@H](CO)[C@H]1O DORPKYRPJIIARM-GYAWPQPFSA-N 0.000 description 5
- QCYLIQBVLZBPNK-UHFFFAOYSA-N asiaticoside A Natural products O1C(C(=O)C(C)C)=CC(C)C(C2(C(OC(C)=O)CC34C5)C)C1CC2(C)C3CCC(C1(C)C)C45CCC1OC1OCC(O)C(O)C1O QCYLIQBVLZBPNK-UHFFFAOYSA-N 0.000 description 4
- 102000006995 beta-Glucosidase Human genes 0.000 description 4
- 108010047754 beta-Glucosidase Proteins 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- WYQVAPGDARQUBT-FGWHUCSPSA-N Madecassol Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(CC[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O WYQVAPGDARQUBT-FGWHUCSPSA-N 0.000 description 3
- WYQVAPGDARQUBT-XCWYDTOWSA-N asiaticoside Natural products O=C(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@H](O)[C@H](O)[C@H](O[C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)[C@@H](CO)O2)O1)[C@@]12[C@@H]([C@@H](C)[C@H](C)CC1)C=1[C@](C)([C@@]3(C)[C@@H]([C@@]4(C)[C@H]([C@@](CO)(C)[C@@H](O)[C@H](O)C4)CC3)CC=1)CC2 WYQVAPGDARQUBT-XCWYDTOWSA-N 0.000 description 3
- 229940022757 asiaticoside Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- NNWMHSNRRWMMBI-PJISEHJASA-N Asiaticoside B Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](OC[C@@H]2[C@H]([C@H](O)[C@@H](O)[C@H](OC(=O)[C@@]34[C@@H](CC(C)(C)CC3)C=3[C@@]([C@]5(C)C[C@@H](O)[C@H]6[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]6(C)[C@H]5CC=3)(C)CC4)O2)O)[C@H](O)[C@H]1O NNWMHSNRRWMMBI-PJISEHJASA-N 0.000 description 2
- 102100021943 C-C motif chemokine 2 Human genes 0.000 description 2
- 101710155857 C-C motif chemokine 2 Proteins 0.000 description 2
- JSQCMNXZFPMWES-WRBXKWMASA-N Centellasaponin B Natural products O=C(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)O1)[C@@]12[C@@H]([C@@H](C)[C@H](C)CC1)C=1[C@](C)([C@@]3(C)[C@@H]([C@]4(C)[C@@H]([C@H](O)C3)[C@@](CO)(C)[C@@H](O)[C@H](O)C4)CC=1)CC2 JSQCMNXZFPMWES-WRBXKWMASA-N 0.000 description 2
- JSQCMNXZFPMWES-UHFFFAOYSA-N Centellasaponin B Chemical compound C1CC(C2(CC(O)C3C(C)(CO)C(O)C(O)CC3(C)C2CC=2)C)(C)C=2C2C(C)C(C)CCC21C(=O)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C(O)C1O JSQCMNXZFPMWES-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- LGOPJRNHNGETGG-UHFFFAOYSA-N scheffoleoside F Natural products CC1OC(OC2C(O)C(O)C(OCC3OC(OC(=O)C45CCC(C)(C)CC4C6=CCC7C8(C)CC(O)C(O)C(C)(CO)C8CCC7(C)C6(C)CC5)C(O)C(O)C3O)OC2CO)C(O)C(O)C1O LGOPJRNHNGETGG-UHFFFAOYSA-N 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 102000003777 Interleukin-1 beta Human genes 0.000 description 1
- 108090000193 Interleukin-1 beta Proteins 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- BNMGUJRJUUDLHW-HCZMHFOYSA-N Madecassoside Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(C[C@@H](O)[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O BNMGUJRJUUDLHW-HCZMHFOYSA-N 0.000 description 1
- BNMGUJRJUUDLHW-HLUHVYOBSA-N Madecassoside Natural products C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5[C@H](O)C[C@@]34C)[C@@H]2[C@H]1C)C(=O)O[C@@H]6O[C@H](CO[C@@H]7O[C@H](CO)[C@@H](O[C@@H]8O[C@H](C)[C@H](O)[C@@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@@H](O)[C@H](O)[C@H]6O BNMGUJRJUUDLHW-HLUHVYOBSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- QDBYXCVLZAHMEZ-UHFFFAOYSA-N Scheffoleoside Natural products CC1OC(OC2C(O)C(O)C(OCC3OC(OC(=O)C45CCC(C)(C)CC4C6=CCC7C8(C)CC(O)C(O)C(C)(C=O)C8CCC7(C)C6(C)CC5)C(O)C(O)C3O)OC2CO)C(O)C(O)C1O QDBYXCVLZAHMEZ-UHFFFAOYSA-N 0.000 description 1
- 206010039710 Scleroderma Diseases 0.000 description 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000003176 fibrotic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 210000000835 hypertrophic cicatrix Anatomy 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- PRAUVHZJPXOEIF-UHFFFAOYSA-N madecassica acid Natural products C1C(O)C(O)C(C)(CO)C2C(O)CC3(C)C4(C)CCC5(C(O)=O)CCC(C)C(C)C5C4=CCC3C21C PRAUVHZJPXOEIF-UHFFFAOYSA-N 0.000 description 1
- 229940090813 madecassoside Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- MQSSVBUAEXUMAK-UHFFFAOYSA-N scheffoleoside A Natural products CC1OC(OC2C(O)C(O)C(OCC3C(O)C(O)C(O)C(OC(=O)C45CCC(C)(C)CC4C6=CCC7C8(C)CC(O)C(O)C(C)(CO)C8CCC7(C)C6(C)CC5)C3O)OC2CO)C(O)C(O)C1O MQSSVBUAEXUMAK-UHFFFAOYSA-N 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
Landscapes
- Steroid Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110358421 CN102367263B (zh) | 2011-11-11 | 2011-11-11 | 一种分离纯化积雪草三萜酸单葡萄糖苷的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110358421 CN102367263B (zh) | 2011-11-11 | 2011-11-11 | 一种分离纯化积雪草三萜酸单葡萄糖苷的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102367263A true CN102367263A (zh) | 2012-03-07 |
CN102367263B CN102367263B (zh) | 2013-05-29 |
Family
ID=45759859
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110358421 Expired - Fee Related CN102367263B (zh) | 2011-11-11 | 2011-11-11 | 一种分离纯化积雪草三萜酸单葡萄糖苷的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102367263B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104510745A (zh) * | 2013-09-30 | 2015-04-15 | 上海医药工业研究院 | 一种三萜皂苷化合物在制备预防或治疗瘢痕增生的药物中的应用 |
CN110870870A (zh) * | 2018-08-29 | 2020-03-10 | 好维股份有限公司 | 一种口腔护理组合物及其在抑制牙龈出血上的应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1774257A (zh) * | 2002-12-10 | 2006-05-17 | 拜尔消费者保健股份公司 | 制备富含羟基积雪草苷和特米诺苷的积雪草酸提取物的方法 |
-
2011
- 2011-11-11 CN CN 201110358421 patent/CN102367263B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1774257A (zh) * | 2002-12-10 | 2006-05-17 | 拜尔消费者保健股份公司 | 制备富含羟基积雪草苷和特米诺苷的积雪草酸提取物的方法 |
Non-Patent Citations (2)
Title |
---|
《色谱》 20070531 潘见等 beta-环糊精流动相添加剂法分离测定积雪草总苷元中的羟基积雪草酸 316-318 1-6 第25卷, 第03期 * |
潘见等: "β-环糊精流动相添加剂法分离测定积雪草总苷元中的羟基积雪草酸", 《色谱》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104510745A (zh) * | 2013-09-30 | 2015-04-15 | 上海医药工业研究院 | 一种三萜皂苷化合物在制备预防或治疗瘢痕增生的药物中的应用 |
CN110870870A (zh) * | 2018-08-29 | 2020-03-10 | 好维股份有限公司 | 一种口腔护理组合物及其在抑制牙龈出血上的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN102367263B (zh) | 2013-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102643322B (zh) | 一种同时制备长梗冬青苷和紫丁香苷的方法 | |
CN102746362A (zh) | 从黄芪中提取精制黄芪甲苷的方法 | |
CN100415760C (zh) | 獐牙菜苦苷单体的分离纯化方法 | |
CN105348192A (zh) | 一种翅荚决明中抗病毒活性的异喹啉生物碱类化合物及其制备方法 | |
CN109879919B (zh) | 一种从酸枣仁中分离制备三种黄酮苷的方法 | |
CN108164579A (zh) | 一种从重楼的地上部分提取分离重楼皂苷h的方法 | |
CN103724390A (zh) | 一种皂苷分离纯化方法 | |
CN101955479A (zh) | 一种从竹叶中提取荭草苷的方法 | |
CN102367263B (zh) | 一种分离纯化积雪草三萜酸单葡萄糖苷的方法 | |
CN106831909B (zh) | 知母须根中双苯吡酮类化合物的提取方法 | |
CN114907184A (zh) | 一种高纯度丹参素钠的提取工艺 | |
CN105175426B (zh) | 一种从四方藤中提取纯化岩白菜素的方法 | |
CN109400665B (zh) | 从毛冬青中制备四种三萜类化合物对照品的方法 | |
CN101955504A (zh) | 高速逆流色谱制备特女贞苷、女贞苦苷和齐墩果酸的方法 | |
CN103102255A (zh) | 一种从香鳞毛蕨中分离纯化四种间苯三酚类化合物的方法 | |
CN105031178A (zh) | 一种高效利用知母的提取精制方法 | |
CN103242390B (zh) | 一种提取去乙酰车叶草苷酸甲酯和鸡矢藤次苷甲酯的方法 | |
CN102670935B (zh) | 一种从藠头中提取总皂苷的方法 | |
CN102311415B (zh) | 一种从了哥王中提取西瑞香素的方法 | |
CN101891729B (zh) | 一种从青天葵中提取高纯度鼠李秦素的方法 | |
CN103570795A (zh) | 一种雷公藤红素的制备方法 | |
CN103880895A (zh) | 一种利用高速逆流色谱分离纯化制备哈巴俄苷和斩龙剑苷a的方法 | |
CN104987354A (zh) | 制备莫诺苷的方法 | |
CN102875635A (zh) | 一种从穿地龙中综合提取原薯蓣皂苷和薯蓣皂苷的方法 | |
CN101973863A (zh) | 一种从草豆蔻中提取小豆蔻明的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: JIANGSU BAICAOTANG PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: SHANGHAI NORMAL UNIVERSITY Effective date: 20150617 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150617 Address after: 225300, No. 5, Mu Lu, pharmaceutical hi tech Zone, Jiangsu, Taizhou Patentee after: Jiangsu baicaotang Pharmaceutical Co.,Ltd. Patentee after: Shanghai new Kang Pharmaceutical Co.,Ltd. Address before: 200234 Xuhui District, Guilin Road, No. 100, Patentee before: Shanghai Normal University Patentee before: Shanghai Xinkang Pharmaceutical Factory |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170607 Address after: 200234 Xuhui District, Guilin Road, No. 100, Patentee after: SHANGHAI NORMAL University Address before: 225300, No. 5, Mu Lu, pharmaceutical hi tech Zone, Jiangsu, Taizhou Co-patentee before: Shanghai new Kang Pharmaceutical Co.,Ltd. Patentee before: Jiangsu baicaotang Pharmaceutical Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130529 Termination date: 20211111 |
|
CF01 | Termination of patent right due to non-payment of annual fee |